1. Home
  2. BNTC vs WW Comparison

BNTC vs WW Comparison

Compare BNTC & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • WW
  • Stock Information
  • Founded
  • BNTC 1995
  • WW 1961
  • Country
  • BNTC United States
  • WW United States
  • Employees
  • BNTC N/A
  • WW N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • WW Other Consumer Services
  • Sector
  • BNTC Health Care
  • WW Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • WW Nasdaq
  • Market Cap
  • BNTC 88.1M
  • WW 75.9M
  • IPO Year
  • BNTC N/A
  • WW 2001
  • Fundamental
  • Price
  • BNTC $11.82
  • WW $1.44
  • Analyst Decision
  • BNTC Buy
  • WW Buy
  • Analyst Count
  • BNTC 6
  • WW 5
  • Target Price
  • BNTC $23.83
  • WW $3.44
  • AVG Volume (30 Days)
  • BNTC 53.1K
  • WW 4.2M
  • Earning Date
  • BNTC 02-11-2025
  • WW 11-06-2024
  • Dividend Yield
  • BNTC N/A
  • WW N/A
  • EPS Growth
  • BNTC N/A
  • WW N/A
  • EPS
  • BNTC N/A
  • WW N/A
  • Revenue
  • BNTC N/A
  • WW $807,465,000.00
  • Revenue This Year
  • BNTC N/A
  • WW N/A
  • Revenue Next Year
  • BNTC N/A
  • WW N/A
  • P/E Ratio
  • BNTC N/A
  • WW N/A
  • Revenue Growth
  • BNTC N/A
  • WW N/A
  • 52 Week Low
  • BNTC $2.69
  • WW $0.67
  • 52 Week High
  • BNTC $13.29
  • WW $9.77
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 62.51
  • WW 55.20
  • Support Level
  • BNTC $11.36
  • WW $1.34
  • Resistance Level
  • BNTC $13.29
  • WW $1.66
  • Average True Range (ATR)
  • BNTC 0.96
  • WW 0.18
  • MACD
  • BNTC 0.23
  • WW 0.02
  • Stochastic Oscillator
  • BNTC 86.05
  • WW 55.56

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

Share on Social Networks: